Abstract:Accurate and timely identification of infections is crucial for effective treatment and controlling disease spread. While single biomarkers have traditionally served diagnostic purposes, their sensitivity and specificity limitations call for a more comprehensive approach. Simultaneous detection of multiple biomolecules shows promise in improving accuracy, expediting analysis, and enhancing pathology screening. Therefore, there is a pressing need to develop a noninvasive biosensor capable of quantifying various infection-associated biomarkers concurrently, such as albumin proteins and bacterial molecules. In this endeavor, a novel biosensor has been developed, leveraging a color-indicating optical platform that utilizes gold nanoisland films (AuNIFs) enveloped by cholesteric liquid crystals (CLCs). The integration of CLCs and AuNIFs capitalizes on their sensitive interfacial interactions, highlighting the potential for robust biosensing. Changes in biomolecule concentrations induce discernible alterations in the CLCs–AuNIFs interface alignment, profoundly impacting the hybrid plasmonic–photonic behavior of AuNIFs. The resulting CLCs–AuNIFs biosensor demonstrates exceptional sensitivity and precision in detecting E. coli concentrations and albumin levels. Notably, the biosensor achieves a label-free limit of detection, with an impressive sensitivity of 1 × 106 CFU/ml for E. coli and 10 ng/ml for bovine serum albumin (BSA). This innovative biosensor offers rapid detection, visual clarity, label-free operation, and the ability to detect multiple concentrations of both microbial agents and albumin. Changes in biomolecule concentrations induce noticeable shifts in interface alignment, thereby modulating the hybrid plasmonic–photonic dynamics of AuNIFs. The potential applications of this advancement span biomedical, microbial, and industrial sectors. This unified biosensor has the potential to revolutionize infection-related diagnostics and containment measures, serving as an ideal point-of-care solution. This ground-breaking development leads the way in multi-biomarker detection in infection diagnosis, with profound implications for future of infection diagnostics and therapeutic interventions.

Colloidal self-assembly in biosensing strategies for biomarkers diagnosis

Self-assembled 1D nanostructures for direct nanoscale detection and biosensing

Recent advances in nanoscale metal-organic frameworks biosensors for detection of biomarkers

High-sensitivity Nanosensors for Biomarker Detection

Amplified biosensing strategies for the detection of biologically related molecules with silica nanoparticles and conjugated polyelectrolytes

Advanced On-Site and in Vitro Signal Amplification Biosensors for Biomolecule Analysis

Pushing the frontiers: Chip-based detection based on micro- and nano-structures

Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing

Dynamic single-molecule sensing by actively tuning binding kinetics for ultrasensitive biomarker detection

Dynamic single-molecule sensing via nanoparticle micromanipulation for rapid and ultrasensitive biomarker detection

Colloidal Nanoparticles for Signal Enhancement in Optical Diagnostic Assays

Integration and synergy in protein-nanomaterial hybrids for biosensing: Strategies and in-field detection applications

Machine Learning-Assisted High-Throughput Identification and Quantification of Protein Biomarkers with Printed Heterochains

Signal Amplification Strategy of DNA Self-Assembled Biosensor and Typical Applications in Pathogenic Microorganism Detection.

Multiscale and Stimuli-Responsive Biosensing in Biomedical Applications: Emerging Biomaterials Based on Aggregation-Induced Emission Luminogens

Nanomaterial-based Multiplex Optical Sensors.

Efficient colorimetric point-of-care detection and imaging of multiple biomolecules utilizing photonic liquid crystal composite on gold nanoisland thin films for label-free sensing

Multi-analyte sensing strategies towards wearable and intelligent devices

Advances in single-molecule fluorescent nanosensors

Ultrasensitive Visual Detection of HIV DNA Biomarkers via a Multi-amplification Nanoplatform

Optical Multiplexed Bioassays for Improved Biomedical Diagnostics.